Elanco CEO granted 116.96 deferred stock units

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health President and CEO Jeffrey N. Simmons reported a routine compensation-related transaction involving deferred stock units. He received an award of 116.9603 deferred stock units, each tied to the value of one share of Elanco common stock at a reference price of $24.17 per unit.

After this grant, his reported balance of deferred stock units increased to 24,541.9486 units. According to the plan terms, these units will settle in either cash or Elanco common shares after his employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.

Insider Trade Summary

Grant/Award: 116.9603 shares

Grant/Award 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	116.9603	$24.17	$3K

Holdings After Transaction: Deferred Stock Units — 24,541.9486 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 116.9603 units Grant reference price: $24.1700 per unit Deferred stock units after grant: 24,541.9486 units +2 more

5 metrics

Deferred stock units granted 116.9603 units Grant of deferred stock units on June 12, 2026

Grant reference price $24.1700 per unit Price used for the deferred stock unit award

Deferred stock units after grant 24,541.9486 units Total deferred stock units following the transaction

Transaction code A (grant, award, or other acquisition) SEC Form 4 transaction characterization

Transaction direction acquire Compensation-related acquisition of derivative units

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, Common Stock

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."

Common Stock financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) CEO Jeffrey Simmons report in this Form 4?

Jeffrey N. Simmons reported receiving 116.9603 deferred stock units as part of his compensation. These units are linked to Elanco common stock and increase his total deferred stock unit holdings to 24,541.9486 units under the company’s Executive Deferral and Stock Match Plan.

Is the Elanco (ELAN) Form 4 transaction a stock purchase or sale?

The Form 4 shows an acquisition coded as a grant or award, not a market purchase or sale. Simmons received 116.9603 deferred stock units as compensation, rather than buying or selling shares in the open market, making this a routine incentive-related transaction.

How are the deferred stock units in Elanco (ELAN) CEO’s Form 4 settled?

Each deferred stock unit represents the right to receive one Elanco common share or the cash equivalent. Settlement occurs after termination of employment or in a specified future year, in line with the company’s Executive Deferral and Stock Match Plan terms described in the filing footnotes.

What is the reference price for the Elanco (ELAN) deferred stock unit grant?

The deferred stock unit grant to Jeffrey N. Simmons uses a reference price of $24.17 per unit. This price is applied to 116.9603 units, helping determine the grant’s notional value even though the units will ultimately settle in either shares or cash.

How many deferred stock units does the Elanco (ELAN) CEO hold after this grant?

Following the reported grant, Jeffrey N. Simmons holds a total of 24,541.9486 deferred stock units. This total reflects his accumulated awards under Elanco’s Executive Deferral and Stock Match Plan and represents rights to future cash or share-settled compensation tied to Elanco common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 04:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	06/12/2026		A		116.9603		(2)	(2)	Common Stock	116.9603	$24.17	24,541.9486	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)